SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.6650
+0.0250 (3.91%)
Mar 18, 2026, 2:01 PM AEST
SomnoMed Market Cap
SomnoMed has a market cap or net worth of 145.26 million as of March 18, 2026. Its market cap has increased by 8.86% in one year.
Market Cap
145.26M
Enterprise Value
133.85M
Revenue
118.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
Market Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 145.26M, an increase of 312.65%. That is a compound annual growth rate of 6.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 139.80M | -17.05% |
| Dec 30, 2025 | 168.55M | 69.55% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 215.38M |
| Aroa Biosurgery | 208.15M |
| EMVision Medical Devices | 148.70M |
| Epiminder | 134.14M |
| Cleo Diagnostics | 64.33M |
| Compumedics | 60.93M |
| HeraMED | 49.12M |
| Micro-X | 47.20M |